Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C09BA05 COMBINAŢII COMPR. 2.5 mg/12.5 mg

(RAMIPRILUM +

HYDROCHLOROTHIAZIDUM)

HARTIL HCT 2,5 mg/12,5 mg 2.5 mg/12.5 mg EGIS PHARMACEUTICALS PLC

PIRAMIL HCT 2,5 mg/12,5 mg 2.5 mg/12.5 mg HEXAL AG

RAMIPRIL HCT-MEDOCHEMIE 2.5 mg/12.5 mg MEDOCHEMIE LTD.
C09BA05 COMBINAŢII COMPR. 2.5 mg + 12.5 mg

(RAMIPRILUM +

HYDROCHLOROTHIAZIDUM)

AMPRIL HL 2.5 mg + 12.5 mg KRKA D.D. NOVO MESTO

C09BA05 COMBINAŢII COMPR. 5 mg/25 mg

(RAMIPRILUM +

HYDROCHLOROTHIAZIDUM)

HARTIL HCT 5 mg/25 mg 5 mg/25 mg EGIS PHARMACEUTICALS PLC

PIRAMIL HCT 5 mg/25 mg 5 mg/25 mg HEXAL AG

RAMIPRIL HCT-MEDOCHEMIE 5 mg/25 mg MEDOCHEMIE LTD.

C09BA05 COMBINAŢII COMPR. 5 mg + 25 mg

(RAMIPRILUM +

HYDROCHLOROTHIAZIDUM)

AMPRIL HD 5 mg + 25 mg KRKA D.D. NOVO MESTO

________________________________________________________________________________
______________________________________________________________________________

| 61 |C09CA01| LOSARTANUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C09CA01 LOSARTANUM COMPR. FILM. 50 mg

COZAAR 50 mg MERCK SHARP & DOHME

ROMANIA S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 62 |C10AA01| SIMVASTATINUM | Protocol: CE01E |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Se utilizează pentru pacienţii care îndeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.